Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis

Published:2012-09 Issue:3 Volume:77 Page:572-577
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Bae Hyun-Mi,Lee Se-Hoon,Kim Tae Min,Kim Dong-Wan,Yang Seok-Chul,Wu Hong Gyun,Kim Young Whan,Heo Dae Seog

Funder

Innovative Research Institute for Cell Therapy

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference22 articles.

1. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial;Rosen;Cancer,2004

2. Bisphosphonates to prevent skeletal morbidity in patients with lung cancer with bone metastases;Price;Clin Lung Cancer,2004

3. Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer;Delea;J Thorac Oncol,2006

4. Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib;Han;J Clin Oncol,2005

5. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer);Thatcher;Lancet,2005

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Femoral bone metastasis is a poor prognostic factor in osimertinib-treated patients with EGFR-mutated non-small cell lung cancer: a retrospective, multicenter study;2024-02-15

2. Femoral bone metastasis is a poor prognostic factor in osimertinib-treated patients with EGFR-mutated non-small cell lung cancer;2023-09-15

3. Construction and Verification of Nomogram Model for Lung Adenocarcinoma With ≤ 5 Bone-Only Metastases Basing on Hematology Markers;Frontiers in Oncology;2022-06-01

4. Prognostic and predictive role of bone metastasis in NSCLC;Unraveling the Complexities of Metastasis;2022

5. Radiation Therapy for Metastatic Lung Cancer: Bone Metastasis and Metastatic Spinal Cord Compression;Medical Radiology;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3